ABBVIE INC. vs. Zentalis Pharmaceuticals, Inc. Common Stock
ABBVIE INC. and Zentalis Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | ZNTL | |
|---|---|---|
| Market Cap | $488.55 billion | $255.61 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-139,545,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | ZNTL | |
|---|---|---|
| Price / Book | — | 1.78 |
ABBV and ZNTL split the valuation factors evenly.
Profitability
| ABBV | ZNTL | |
|---|---|---|
| Return on Equity | — | -97.15% |
ABBV and ZNTL split the profitability factors evenly.
Dividend
| ABBV | ZNTL | |
|---|---|---|
| Dividend Yield | 2.50% | — |
ABBV and ZNTL split the dividend factors evenly.
Risk & Sentiment
| ABBV | ZNTL | |
|---|---|---|
| Short Interest | 0.85% | 0.64% |
ZNTL leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, ZNTL overview, ZNTL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.